Abstract
BackgroundRituximab has been used for patients with refractory myositis in many centers, including ours. In a large double-blind trial on rituximab in inflammatory myopathies, no significant difference has been found...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
